| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |